Stay updated on Ipilimumab Plus Talimogene Laherparepvec Clinical Trial
Sign up to get notified when there's something new on the Ipilimumab Plus Talimogene Laherparepvec Clinical Trial page.
Latest updates to the Ipilimumab Plus Talimogene Laherparepvec Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page footer revision tag updated from v3.2.0 to v3.3.2. No study data or core functionality appears to be affected.SummaryDifference0.0%
- Check27 days agoChange DetectedAdded related topics Melanoma and MedlinePlus Genetics to the page, and removed the government funding status notice. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%
- Check35 days agoChange DetectedThe Melanoma topic and the MedlinePlus Genetics related topics were removed from the page's related topics section.SummaryDifference0.1%
- Check49 days agoChange DetectedNo substantive changes detected between the two screenshots; the page still presents the Study Details for NCT01740297 with the same sections (Overview, Eligibility Criteria, Plan, Contacts and Locations).SummaryDifference0.3%
- Check63 days agoChange DetectedRemoved the MedlinePlus Genetics topic Melanoma from the page, reducing the page’s coverage of genetic topics related to melanoma.SummaryDifference0.1%
- Check70 days agoChange DetectedAdded a prominent operating-status notice and a new version tag (v3.2.0); removed the old version tag (v3.1.0).SummaryDifference2%
Stay in the know with updates to Ipilimumab Plus Talimogene Laherparepvec Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipilimumab Plus Talimogene Laherparepvec Clinical Trial page.